Hence, it is not surprising that we only found a single mutation (a mutation on codon 220 that leads to a change from tyrosine to cysteine), already described in BC and present in only six of the 346 patients with mutated TP53 in TCGA BC cohort. The gene discussed is TP53; the disease is breast cancer.